Biotech Company Pumps 56%

Good morning Wake-Up Watchlisters! While you’re sipping coffee you’ll see stocks wavered on Tuesday. It feels like a broken record at this point – but China’s widening Covid lockdowns and uncertain Fedspeak regarding interest rates continue to weigh on investors.

With more volatility potentially ahead, it’s important to look at stocks that are going to be around after all the smoke clears. Our Head Fundamental Tactician Karim Rahemtulla is high on this one company that has a foothold in many emerging technologies.

Click here to discover this $2 stock.

Here’s a look at the top-moving stocks this morning.

ObsEva SA (Nasdaq: OBSV)

ObsEva SA is up 55.71% premarket after the biopharmaceutical company for women’s health announced the sale of all the company’s rights to Ebopiprant to XOMA Corporation for an upfront payment of $15 million and future milestone payments of up to $98 million. Under the terms of the agreement, ObsEva will sell and assign all its rights to Ebopiprant, which is an orally active potential treatment for preterm labor inflammation and uterine contractions.

Biotech companies have some of the best potential for big gains. Right now our friend Alexander Green is pounding the table on this up-and-coming healthcare company. It has the patent on a medical device that’s been called ‘the biggest healthcare innovation in half a century.’ And at just $3, our friend Alexander Green is calling it ‘the most incredible investment opportunity I’ve seen in 37 years.’

Click here to unlock this $3 stock.

Bakkt Holdings, Inc. (NYSE: BKKT)

Bakkt Holdings is up 10.84% premarket. The crypto company recently confirmed it had no exposure to FTX, FTT, Almaeda or other affected companies by the recent FTX scandal. And earlier this month, Bakkt reached a definitive agreement to acquire Apex Crypto LLC, another company with no direct exposure to FTX, Almaeda or FTT.

Zoom Video Communications (Nasdaq: ZM)

Zoom Video Communications is down 9.34% premarket after cutting its fourth quarter and full-year revenue guidance. Zoom sees full-year revenue of $4.37 billion to $4.38 billion, lower than its prior view of $4.39 billion to $4.40 billion. For the third quarter, Zoom reported adjusted earnings of $1.07 per share on revenue of $1.10 billion.

Just because a stock goes down doesn’t mean you have to lose money. If you want to see how we can make trades that profit no matter if a stock rises or falls, then we invite you to join The War Room. We have a 77% win rate in 2022 and right now we’re guaranteeing members receive 252 winning trades in their first 12 months of membership.

Click here to join The War Room.

Celanese Corporation (NYSE: CE)

Celanese Corporation is up 10.22% premarket after the global specialty materials and chemical company announced it will increase prices for a range of products. The price increases are expected to start on December 1, 2022. Certain grades may also be subject to higher increases.

Those are the top market movers today.

Happy trading!

The Wake-Up Watchlist Research Team